Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US OK's ViroSeq for use in larger laboratories:

This article was originally published in Clinica

Executive Summary

Celera Diagnostics has received US FDA 510(k) clearance to use its ViroSeq HIV-1 genotyping system with the ABI PRISM 3700 DNA analyser, a fully automated instrument commonly used in the largest, high-throughput clinical testing laboratories. The ViroSeq system, which detects mutations in the HIV-1 virus that are associated with drug resistance, is already cleared for use with analysers aimed at small and mid-sized throughput centres, according to the Alameda, California firm. It is distributed exclusively by Abbott Laboratories.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT062742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel